单纯脑膜瘤栓塞:一项系统综述
该系统综述纳入34项研究、121例仅接受栓塞(术后至少2个月未行切除或放疗)的脑膜瘤患者,其中67例有长期随访。有症状患者中77±6%症状改善,84±6%影像学肿瘤缩小,5%完全消退;主要并发症率5%,与术前栓塞(3%-6%)相当,低于手术切除(7%-31%)。
要点
- 单纯栓塞可用于不适合手术或标准治疗难治的脑膜瘤患者
- 有症状者症状改善77±6%,影像学缩小84±6%
- 主要并发症率5%,低于手术切除的7%-31%
核心结论
- 单纯栓塞可能为不适合手术或对标准治疗难治的脑膜瘤患者提供低风险替代方案。
- 现有证据有限且多为回顾性,报告结局支持进一步前瞻性研究。
- 缺血诱导的坏死可能是肿瘤及症状消退的机制。
研究设计与样本
- 遵循PRISMA指南的系统综述,检索PubMed/MEDLINE与EMBASE。
- 单纯栓塞定义为栓塞后至少2个月未行切除或放疗。
- 两名盲法评审用Covidence筛选并标准化提取数据。
- 共纳入34项研究、121例患者,其中67例有长期随访。
主要发现
- 有症状患者中77±6%报告症状改善。
- 84±6%观察到影像学肿瘤缩小,5%完全消退。
- 主要并发症率为5%。
- 主要并发症率与术前栓塞(3%-6%)相当,低于手术切除(7%-31%)。
关键数值与推荐
- 脑膜瘤为最常见原发颅内肿瘤,每年新发超过450 000例。
- 手术切除为标准治疗,但复发率高达40%。
- 单纯栓塞后至少2个月未行切除或放疗方符合定义。
临床怎么用
- 对不适合手术或标准治疗难治的脑膜瘤,可考虑单纯栓塞作为替代或姑息选择。
- 决策时需权衡5%的主要并发症风险与手术切除7%-31%的并发症率。
- 应告知患者现有证据多为回顾性、样本量有限。
局限性
- 现有证据有限,研究多为回顾性。
- 121例中仅67例有长期随访。
- 需更大规模研究确证单纯栓塞的安全性与有效性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Meningiomas are the most common primary intracranial tumors, with over 450 000 new cases each year. Although surgical resection remains the standard of care, recurrence occurs in up to 40% of cases. Reoperation poses additional risks due to anatomic changes and scar tissue. Elderly and frail patients experience increased rates of surgical morbidity, limiting treatment options. This study evaluates the potential of embolization, a technique traditionally used preoperatively to reduce intraoperative blood loss, as a definitive or palliative standalone treatment in select cases. METHODS: A systematic review was conducted following Preferred Reporting Items for System reviews and Meta-Analyses guidelines. PubMed/MEDLINE and EMBASE were searched for studies reporting standalone meningioma embolization, defined as embolization without resection or radiotherapy for at least 2 months postprocedure. Two blinded reviewers screened articles using Covidence and conducted standardized data extraction. Variables collected included patient demographics, tumor characteristics, embolic agents, outcomes, and complications. RESULTS: This review identified 121 patients across 34 studies treated with standalone embolization. Of these, 67 patients had long-term follow-up. Symptomatic improvement was reported in 77 ± 6% of symptomatic patients, with radiographic tumor shrinkage observed in 84 ± 6%, and complete resolution seen in 5%. The major complication rate (5%) was comparable with that of preoperative embolization (3%-6%) and lower than that of surgical resection (7%-31%). CONCLUSION: Standalone embolization potentially represents a lower-risk alternative for meningioma patients unsuitable for surgery or refractory to standard treatments. Although current evidence is limited and largely retrospective, reported outcomes support further prospective investigation. Mechanistically, ischemia-induced necrosis may be the underlying cause of tumor and symptom regression. Larger studies are needed to establish standalone embolization as a safe and effective meningioma treatment.
引用
- Odland IC, Huo L, Feng R, et al. Standalone Meningioma Embolization: A Systematic Review. Neurosurgery. 2026. PMID: 41660991. doi:10.1227/neu.0000000000003933
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。